Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 314

1.

Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk.

Zhang C, Li C, Zhu M, Zhang Q, Xie Z, Niu G, Song X, Jin L, Li G, Zheng H.

PLoS One. 2013 Apr 24;8(4):e62023. doi: 10.1371/journal.pone.0062023. Print 2013.

2.

Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis.

Hu C, Wang J, Xu Y, Li X, Chen H, Bunjhoo H, Xiong W, Xu Y, Zhao J.

Gene. 2013 Mar 15;517(1):65-71. doi: 10.1016/j.gene.2012.12.085. Epub 2013 Jan 9.

PMID:
23313298
3.

Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm.

Saracini C, Bolli P, Sticchi E, Pratesi G, Pulli R, Sofi F, Pratesi C, Gensini GF, Abbate R, Giusti B.

J Vasc Surg. 2012 Jan;55(1):171-179.e2. doi: 10.1016/j.jvs.2011.07.051. Epub 2011 Nov 16.

4.

Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.

Pereza N, Ostojić S, Volk M, Kapović M, Peterlin B.

Reprod Biomed Online. 2012 May;24(5):567-75. doi: 10.1016/j.rbmo.2012.01.008. Epub 2012 Jan 24.

PMID:
22406112
5.

Genetic polymorphisms in MMP 2, 9 and 3 genes modify lung cancer risk and survival.

González-Arriaga P, Pascual T, García-Alvarez A, Fernández-Somoano A, López-Cima MF, Tardón A.

BMC Cancer. 2012 Mar 28;12:121. doi: 10.1186/1471-2407-12-121.

6.

Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies.

Peng B, Cao L, Wang W, Xian L, Jiang D, Zhao J, Zhang Z, Wang X, Yu L.

Mutagenesis. 2010 Jan;25(1):41-8. doi: 10.1093/mutage/gep041. Epub 2009 Oct 20.

PMID:
19843588
7.

Association between MMP1 -1607 1G>2G polymorphism and head and neck cancer risk: a meta-analysis.

Zhang C, Song X, Zhu M, Shi S, Li M, Jin L, Lang J, Li G, Zheng H.

PLoS One. 2013;8(2):e56294. doi: 10.1371/journal.pone.0056294. Epub 2013 Feb 18.

8.

Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk.

Peng B, Cao L, Ma X, Wang W, Wang D, Yu L.

Mutagenesis. 2010 Jul;25(4):371-9. doi: 10.1093/mutage/geq015. Epub 2010 Apr 1.

PMID:
20360147
9.

Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: a meta-analysis.

Liu D, Guo H, Li Y, Xu X, Yang K, Bai Y.

PLoS One. 2012;7(2):e31251. doi: 10.1371/journal.pone.0031251. Epub 2012 Feb 14.

10.
11.

Variations in matrix metalloproteinase-1, -3, and -9 genes and the risk of acute coronary syndrome and coronary artery disease in the Chinese Han population.

Xu X, Wang L, Xu C, Zhang P, Yong F, Liu H, Wang J, Shi Y.

Coron Artery Dis. 2013 Jun;24(4):259-65. doi: 10.1097/MCA.0b013e32835ea3af.

PMID:
23377317
12.

Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.

Zinzindohoué F, Blons H, Hans S, Loriot MA, Houllier AM, Brasnu D, Laccourreye O, Tregouet DA, Stucker I, Laurent-Puig P.

Anticancer Res. 2004 May-Jun;24(3b):2021-6.

13.

Meta-analysis of associations between polymorphisms in the promoter regions of matrix metalloproteinases and the risk of colorectal cancer.

Liu D, Duan W, Guo H, Xu X, Bai Y.

Int J Colorectal Dis. 2011 Sep;26(9):1099-105. doi: 10.1007/s00384-011-1198-4. Epub 2011 May 3.

PMID:
21538057
14.

Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions.

Chaudhary AK, Singh M, Bharti AC, Singh M, Shukla S, Singh AK, Mehrotra R.

BMC Cancer. 2010 Jul 14;10:369. doi: 10.1186/1471-2407-10-369.

15.

The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer.

Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Köppel H, Leithner A, Wascher TC, Paulweber B, Samonigg H.

Clin Cancer Res. 2004 May 15;10(10):3518-20.

16.

Haplotype analysis of the stromelysin-1 (MMP3) and gelatinase B (MMP9) genes in relation to coronary heart disease.

Wu N, Lu X, Hua Y, Song L, Ye J, Li J, Meng X, Gu D, Yang Y.

Ann Hum Genet. 2009 Jul;73(Pt 4):404-10. doi: 10.1111/j.1469-1809.2009.00522.x. Epub 2009 May 11.

17.

Matrix metalloproteinase-9 gene -1562C/T polymorphism mitigates preeclampsia.

Coolman M, de Maat M, Van Heerde WL, Felida L, Schoormans S, Steegers EA, Bertina RM, de Groot CJ.

Placenta. 2007 Jul;28(7):709-13. Epub 2006 Nov 28.

PMID:
17137622
18.

Matrix metalloproteinase3 gene promoter polymorphisms and their haplotypes are associated with gastric cancer risk in eastern Indian population.

Dey S, Stalin S, Gupta A, Saha D, Kesh K, Swarnakar S.

Mol Carcinog. 2012 Oct;51 Suppl 1:E42-53. doi: 10.1002/mc.21837. Epub 2011 Nov 28.

PMID:
22121090
19.

[Association of the MMP3, MMP9, ADAM33 and TIMP3 genes polymorphic markers with development and progression of chronic obstructive pulmonary disease].

Korytina GF, Tselousova OS, Akhmadishina LZ, Victorova EV, Zagidullin ShZ, Victorova TV.

Mol Biol (Mosk). 2012 May-Jun;46(3):487-99. Russian.

PMID:
22888638
20.

Matrix metalloproteinase variants associated with risk and clinical outcome of esophageal cancer.

Zhang L, Xi RX, Zhang XZ.

Genet Mol Res. 2015 May 4;14(2):4616-24. doi: 10.4238/2015.May.4.20.

Supplemental Content

Support Center